Business Description

Baxter International Inc., founded in 1931 and headquartered in Deerfield, Illinois, United States, is a global healthcare company focused on innovative medical devices, pharmaceuticals, and biotechnology products. It is best known for its advanced renal care systems, infusion pumps, and sterile solutions, which drive recurring revenue across hospitals and home care segments. Under the leadership of CEO José E. Almeida since 2016, Baxter maintains a top-five global ranking in its core markets. The company is actively investing in next-generation therapies and digital health initiatives while expanding its footprint in emerging markets.

Everything on Baxter International Inc.

Revenue (FY2025) $11.24B
YoY growth +5.7%
Operating margin -2.7%
Direction Expanding
Gross margin 30.1%
Net margin -8.0%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Andrew P. Hider — President & CEO View full profile ↗ Brent Shafer — Non-Executive Chair of the Board View full profile ↗ William A. Ampofo II — Director View full profile ↗ Jeffrey A. Craig — Director View full profile ↗ Michael R. McDonnell — Director View full profile ↗ Patricia B. Morrison — Director View full profile ↗ Nancy M. Schlichting — Director View full profile ↗ Amy A. Wendell — Director View full profile ↗ David S. Wilkes, M.D. — Director View full profile ↗ Joel Grade — Executive Vice President & Chief Financial Officer View full profile ↗ Anita Zielinski — Senior Vice President & Chief Accounting Officer; Interim CFO (departing, effective September 15, 2026) View full profile ↗ Heather Knight — Executive Vice President, Chief Operating Officer & Interim Group President, Medical Products & Therapies View full profile ↗ Reazur Rasul — Executive Vice President & Group President, Healthcare Systems & Technologies View full profile ↗ David Rosenbloom — Executive Vice President & General Counsel View full profile ↗ Alok Sonig — Executive Vice President & Group President, Pharmaceuticals View full profile ↗ Maria (Cecilia) Soriano — Group President, Infusion Therapies & Technologies (ITT) and Pharmaceuticals View full profile ↗
Baxter International acquires Gambro AB — Renal / dialysis · 2013 View full deal ↗ Baxter International acquires Hill-Rom Holdings, Inc. (Hillrom) — Connected care / medical technology · 2021 View full deal ↗ Baxter International acquires Claris Injectables Limited (Claris) — Generic injectable pharmaceuticals · 2017 View full deal ↗ Baxter International acquires Seprafilm Adhesion Barrier (product rights, from Sanofi) — Surgical / adhesion prevention · 2020 View full deal ↗ Baxter International acquires Synovis Life Technologies, Inc. — BioSurgery / soft-tissue repair · 2011 View full deal ↗ Baxter International acquires Caelyx and Doxil rights (ex-US, from a subsidiary of Johnson & Johnson) — Oncology pharmaceuticals · 2021 View full deal ↗ Baxter International acquires Cheetah Medical, Inc. (Cheetah) — Patient monitoring / hemodynamic monitoring · 2019 View full deal ↗ Baxter International acquires RECOTHROM and PREVELEAK products (from Mallinckrodt plc) — BioSurgery / hemostats and sealants · 2018 View full deal ↗ Baxter International acquires Transderm Scop (TDS) rights (from subsidiaries of GlaxoSmithKline) — Pharmaceuticals · 2021 View full deal ↗ Baxter International acquires PerClot Polysaccharide Hemostatic System (assets, from CryoLife, Inc.) — BioSurgery / hemostats · 2021 View full deal ↗ Baxter International acquires Baxa Corporation — Medical Products · 2011 View full deal ↗ Baxter International acquires SIGMA International General Medical Apparatus, LLC — Medical Products · 2012 View full deal ↗

Share Repurchase Program

Remaining (as of March 31, 2026)
$1.30 billion
Latest FY repurchased
$0 (no shares repurchased in 2025 or 2024)

Recent SEC Filings

2026-05-08 Leadership change (directors/officers) (+2 more) View filing ↗
2026-04-30 Reported quarterly results (+1 more) View filing ↗
2026-03-19 Regulation FD disclosure View filing ↗
2026-03-16 Leadership change (directors/officers) (+1 more) View filing ↗
2026-02-12 Reported quarterly results (+2 more) View filing ↗
2025-12-22 Other event View filing ↗
2025-12-04 Entered a material agreement (+3 more) View filing ↗
2025-11-25 Entered a material agreement View filing ↗
2025-11-19 Other event View filing ↗
2025-11-19 Other event View filing ↗
2025-11-12 Leadership change (directors/officers) View filing ↗
2025-10-30 Reported quarterly results View filing ↗

More Companies

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.